NEW YORK (GenomeWeb) – Roche said today that the US Food and Drug Administration has approved an additional claim for its Cobas Zika test for use on the Cobas 6800 and 8800 systems that enables streamlined screening of multiple individual blood or plasma donations that have been pooled together.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.